Public cistromeDB data confirmed AR occupancy at these sites in PCa cells and fibroblasts (Fig. 2L), and clinical ChIP-seq analyses showed higher AR binding at the OPRK1 promoter in tumors relative to normal prostate tissue (Fig. 2M). The gene discussed is OPRK1; the disease is posterior cortical atrophy.